If the science is successful, and if management can navigate this ship just right, CVac - and by corollary, Prima Biomed - could become a singularly unique one-stop shop for various cancer treatments.
As such, management will have added tremendous additional value then if it had only applied the science to one form of cancer: ovarian.
In the business world, nothing beats a robust monopoly.
Yes, the risks are high, but so too are the rewards. Except in this case, the rewards will be even higher.
In my opinion, and judging by cashed-up insiders, the risks are very much to the upside. One thing's for sure, there's no inbetween here. It's either boom or bust.
I say ... BOOM!!!
If the science is successful, and if management can navigate...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.3¢ |
Change
0.003(0.63%) |
Mkt cap ! $584.6M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 40.5¢ | 40.0¢ | $194.3K | 483.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 156213 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 43766 | 11 |
View Market Depth
| Last trade - 11.00am 12/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |